Training for professionals
Patient care will improve if we increase knowledge and teaching. For this reason, training is one of the key activities of our network. This includes the organization of postgraduate schools, workshops and webinars for doctors and student doctors specialising in rare liver diseases. In addition, specialist nurse training is a key part of our activities.
Training videos
Liver transplantation
Autoimmune Hepatitis (AIH)
Click here to view
Primary sclerosing cholangitis (PSC)
Click here to view
Webinars
Our educational webinars are primarily aimed at physicians, but open to all. They take place on the second Tuesday of the month, at 5 p.m.
|
Date and Topic |
Chairs/ Speakers |
More Information |
|---|---|---|
|
10/11/2020 |
Joost PH Drenth, Thijs Barten, Titus Wijnands, Marten Lantinga (Radboud UMC, Nijmegen) |
https://rare-liver.eu/news/detail/webinar-cyst-infection-10-november-2020 |
|
15/12/2020 |
Ekkehard Sturm, Johannes Hilberath, Martin Schuhmann, Andrea Bevot (University of Tuebingen, Children´s Hospital) |
https://rare-liver.eu/news/detail/webinar-palf-15-december-2020 |
|
12/01/2021 |
Mathias Ruiz (Hôpital Femme Mère Enfant du CHU de Lyon); |
|
|
09/02/2021 |
Karl-Heinz Weiss (Krankenhaus Salem der Evang. Stadtmission Heidelberg) |
https://rare-liver.eu/news/detail/webinar-wilsons-disease-9-2-2021 |
|
09/03/2021 |
Julien Calderaro (Hôpital Henri Mondor, Créteil); |
https://rare-liver.eu/news/detail/webinar-rare-liver-tumours-932021 |
|
13/04/2021 |
Pietro Invernizzi, Marco Carbone (Ospedale San Gerardo Monza); |
https://rare-liver.eu/news/detail/webinar-pbc-therapy-1342021 |
|
11/05/2021 |
Andrea De Gottardi (Ospedale Italiano di Lugano); |
https://rare-liver.eu/news/detail/webinar-porto-sinusoidal-vascular-disease-1152021 |
|
—— The webinar in June will be replaced by the BARD webinar and WCPGHAN —— |
BARD Webinar: http://www.bard-online.com/ |
|
|
13/07/2021 |
Eleonora De Martin (Hôpital Paul Brousse, AP-HP Paris); |
https://rare-liver.eu/news/detail/webinar-treatment-of-autoimmune-hepatitis-13072021 |
|
—— August: Summer break —— |
||
|
14/09/2021 |
Marianne Hørby Jørgensen, Henriette Ytting (Rigshospitalet, Copenhagen); |
|
|
09/11/2021 |
Emmanuel Gonzales (Hôpital Bicêtre, Paris) |
|
Further webinars by our partners
Further webinars on liver diseases are regularly provided by our partners: > ESPGHAN < – > Young ESPGHAN < – > EASL <
COVID-19 Webinar organized by the European Commission – DG SANTE with ERN RARE-LIVER
In the context of the “COVID-19 Clinical Management Support System” launched by the European Commission, DG SANTE organises a series of webinars to support clinicians and other healthcare professionals at the frontline of the care of COVID-19 patients. On 10 June 2020, Prof. Dr. Ansgar W. Lohse, ERN RARE-LIVER Coordinator, Director and Chairman, I. Department of Medicine in University Medical Center Hamburg-Eppendorf, Germany, Prof. Dr. Jörn M. Schattenberg, Metabolic Liver Research Program, I. Department of Medicine in University Medical Center Mainz, Germany, Priv.-Doz. Dr. med. Julian Schulze zur Wiesch, Medical Specialist in Internal Medicin in University Medical Center Hamburg-Eppendorf all contributed to the webinar entitled, “COVID-19 and Rare Liver diseases”.
Disease-specific Training material
You can find training material for Healthcare Professionals about diseases covered by ERN RARE-LIVER here . This includes descriptions of the diseases, training videos and leaflets. We are constantly working to add new content.
AIH Histopathology Workshop
Two workshops on histological criteria of Autoimmune Hepatitis (AIH) have been held.
The first workshop was organized as a joint initiative of the ERN RARE-LIVER and the European Society of Pathology (ESP). At this workshop, the world’s experts in the field reached a consensus on an update of the histological criteria for AIH, for the first time also developing criteria for the diagnosis of acute AIH. Furthermore, initial steps for an international study to validate these updated histological criteria for AIH were taken.
The consensus reached at the first meeting was finalized by a final Delphi round. Results were discussed during a second online Workshop. These considerations and recommendations will be published in due course.
The results of these workshops and the planned study are an important step towards improving AIH patient care, since they will help to make a better diagnosis. They will also offer better guidance for treatment and they will thus help to test new drugs for AIH in clinical trials aiming at more specific, less toxic and more effective therapies for AIH.